,,iv #aaf? ,,congress #a/ ,session ,h4 ,,res4 #afa ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,febru>y #bh1 #bjai,mr4 ,c>son ( ,indiana submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ! la/ day ( ,febru>y ea* ye> z ,r>e ,disease ,day4 ,:]eas r>e diseases & disord]s are ^? :i* affect small pati5t populations1 typically populations small] ?an #bjj1jjj individuals 9 ! ,unit$ ,/ates2 ,:]eas m ?an #g1jjj r>e diseases affect approximately #cj1jjj1jjj p 9 ! ,unit$ ,/ates & _! families2 ,:]eas *ildr5 ) r>e diseases acc\nt = a significant proportion ( ! population affect$ by r>e diseases2 ,:]eas _m r>e diseases are s]i\s1 life-?reat5+1 & lack an effective treatm5t2 ,:]eas r>e diseases & conditions cross ! m$ical spectrum2 ,:]eas individuals ) r>e diseases exp]i5ce *all5ges t include difficulty 9 obta9+ an accurate diagnosis1 limit$ treatm5t options1 & difficulty f9d+ physicians or treatm5t c5t]s ) exp]tise 9 _! disease2 ,:]eas al?\gh ov] #gej drugs & biologics h be5 approv$ = ! treatm5t ( r>e diseases by ! ,food & ,drug ,adm9i/ration1 millions ( p 9 ! ,unit$ ,/ates h r>e diseases = :i* !re is no approv$ treatm5t2 ,:]eas lack ( effective treatm5ts & difficulty 9 obta9+ reimbursem5t = life-alt]+ & (t5 life-sav+ treatm5ts rema9 significant *all5ges = individuals ) r>e diseases & _! families2 ,:]eas z a result ( ! ,orphan ,drug ,act1 !re h be5 important advances 9 rese>* ( & treatm5t = r>e diseases2 ,:]eas ! ,food & ,drug ,adm9i/ration has tak5 great /rides 9 ga!r+ pati5t p]spectives to in=m ! drug review process z "p ( its ,pati5t-,focus$ ,drug ,developm5t program1 an initiative t 0 reaffirm$ "u ! ,food & ,drug ,adm9i/ration ,reau?orization ,act ( #bjag2 ,:]eas ! #aae? ,congress pass$ a #aj-ye> ext5sion ( ! ,*ildr5's ,heal? ,insurance ,program1 ensur+ cov]age = _m *ildr5 ) r>e diseases2 ,:]eas bo? ! ,food & ,drug ,adm9i/ration & ! ,national ,in/itutes ( ,heal? h e/abli%$ special (fices to support & facilitate r>e disease rese>* & treatm5ts2 ,:]eas ! ,national ,organization = ,r>e ,disord]s1 a nonpr(it organization e/abli%$ 9 #aihc to provide s]vices to1 & advocate on behalf (1 pati5ts ) r>e diseases1 rema9s a critical public voice = p ) r>e diseases2 ,:]eas ! ,national ,organization = ,r>e ,disord]s sponsors ,r>e ,disease ,day 9 ! ,unit$ ,/ates & p>tn]s ) _m o!r major r>e disease organizations to increase public aw>5ess ( r>e diseases2 ,:]eas ,r>e ,disease ,day is obs]v$ ea* ye> on ! la/ day ( ,febru>y2 ,:]eas ,r>e ,disease ,day 0 obs]v$ 9 ! ,unit$ ,/ates = ! fir/ "t on ,febru>y #bh1 #bjji1 & obs]v$ 9 m ?an #ij c\ntries 9 #bjah2 & ,:]eas ,r>e ,disease ,day is expect$ to be obs]v$ globally 9 ye>s to come1 provid+ hope & in=mation = r>e disease pati5ts ar\nd ! _w3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,r>e ,disease ,day2 7#b7 recognizes ! importance ( improv+ aw>5ess & enc\rag+ accurate & e>ly diagnosis ( r>e diseases & disord]s2 & 7#c7 supports a national & global commitm5t to improv+ access to1 & develop+ new treatm5ts1 diagno/ics1 & cures =1 r>e diseases & disord]s4